TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8219653

Group type: EXPERIMENTAL
Intervention: Human atrial natriuretic peptide (hANP) levels in type 1 diabetic patients
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Mean arterial blood pressure
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Increased urinary albumin excretion
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: hANP levels and metabolic control
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Normal vs elevated urinary albumin excretion
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Increased urinary albumin and alpha-1-microglobulin excretion
Number of subjects: 83
Study: 3304705

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 30 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine 100 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 12
Study: 29950671

Group type: EXPERIMENTAL
Intervention: House cleaning intervention (including instruction on proper technique and cleaning supplies) for 1 week
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hand washing intervention (including instruction on proper technique and soaps) for 1 week
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combined interventions (house cleaning and hand washing) for 1 week
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: House cleaning intervention (for women with exposure above the median at baseline)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hand washing intervention (for women with exposure above the median at baseline)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combined interventions (for women with exposure above the median at baseline)
Number of subjects: 32
Study: 27140941

Group type: EXPERIMENTAL
Intervention: Repeated-sprint training in hypoxia (RSH, FiO2 = 13.8%)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Repeated-sprint training in normoxia (RSN, FiO2 = 20.9%)
Number of subjects: 15
Study: 26468063

Group type: EXPERIMENTAL
Intervention: MOA-III
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 36
Study: 23958608

Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 10 minutes
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 20 minutes
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 30 minutes
Number of subjects: 99

Group type: COMPARATOR
Intervention: Pretest measurements
Number of subjects: 99
Study: 21837837

Group type: EXPERIMENTAL
Intervention: Various physiotherapeutic modalities
Number of subjects: 0
Study: 18996379

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with porfimer sodium combined with acid suppression (PHOPDT)
Number of subjects: 208

Group type: COMPARATOR
Intervention: 20 mg omeprazole twice daily (control)
Number of subjects: 208
Study: 16670912

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 252
Study: 15449078

Group type: EXPERIMENTAL
Intervention: COREFO questionnaire
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Hallbook questionnaire
Number of subjects: 257

Group type: COMPARATOR
Intervention: Vaizey questionnaire
Number of subjects: 257
Study: 10999815

Group type: EXPERIMENTAL
Intervention: rhLH, 900 IU/day sc
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: rhFSH, 150 IU/day sc
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: rhLH plus rhFSH
Number of subjects: 6

Group type: COMPARATOR
Intervention: rhFSH
Number of subjects: 6

Group type: COMPARATOR
Intervention: rhLH
Number of subjects: 6
Study: 9282238

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane (experimental rabbits)
Number of subjects: 30
Study: 8378890

Group type: EXPERIMENTAL
Intervention: Breast‐preserving therapy (BCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mastectomy without postoperative irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation after tumorectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 0
Study: 2439818

Group type: EXPERIMENTAL
Intervention: Bopindolol
Number of subjects: 24
Study: 3137593

Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.125 microgram/kg/min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.25 microgram/kg/min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.5 microgram/kg/min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31910432

Group type: EXPERIMENTAL
Intervention: SNP-methylation combinations associated with SCZ
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Convergent functional genomics method
Number of subjects: 15
Study: 31218860

Group type: EXPERIMENTAL
Intervention: Icon infiltrant resin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Filtek Z250, Filtek Z350 XT, Beautiful Flow Plus F00
Number of subjects: 40
Study: 29032110

Group type: EXPERIMENTAL
Intervention: CXL graft group (Group 1)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional graft group (Group 2)
Number of subjects: 116
Study: 26171733

Group type: EXPERIMENTAL
Intervention: SmartQuit smartphone app
Number of subjects: 98
Study: 23190756

Group type: EXPERIMENTAL
Intervention: Adequate amount of dairy food (AD), equivalent to ≥711 mL/d milk
Number of subjects: 51

Group type: COMPARATOR
Intervention: Low amount of dairy food (LD), equivalent to ≤238 mL/d milk
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Energy restriction
Number of subjects: 51
Study: 22097203

Group type: COMPARATOR
Intervention: Calcichew D3 Tablet
Number of subjects: 135

Group type: COMPARATOR
Intervention: Calcichew D3 Tablet and Xianling Gubao Capsule
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Calcichew D5 Tablet and embedding thread according to staging and wholism syndrome differentiation
Number of subjects: 135
Study: 19541504

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (220 mg zinc sulfate capsule)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (220 mg corn starch)
Number of subjects: 55
Study: 16274713

Group type: EXPERIMENTAL
Intervention: Heat therapy (50 degrees C for 30s, applied once)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucantime therapy (antimonial, administered for 20 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucantime therapy
Number of subjects: 0
Study: 15467324

Group type: EXPERIMENTAL
Intervention: Respimat SMI
Number of subjects: 660

Group type: COMPARATOR
Intervention: CFC-MDI
Number of subjects: 660
Study: 11081698

Group type: EXPERIMENTAL
Intervention: Cued comprehension strategies
Number of subjects: 220
Study: 9028548

Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg/day G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg/day G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 16 micrograms/kg/day G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Cost of G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Higher doses of G-CSF
Number of subjects: 57
Study: 8103267

Group type: EXPERIMENTAL
Intervention: Phototrichogram
Number of subjects: 12
Study: 3511405

Group type: EXPERIMENTAL
Intervention: Low-dose bromocriptine (15 mg daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 27781390

Group type: EXPERIMENTAL
Intervention: Multicomponent nutritional supplement for 24 weeks
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 194
Study: 27079964

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin T
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide
Number of subjects: 128
Study: 24304938

Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs), n = 401
Number of subjects: 895

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 895
Study: 22729115

Group type: EXPERIMENTAL
Intervention: Modified GVL blade with a tube conduit
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional GVL blade and rigid intubating stylet
Number of subjects: 60
Study: 19398145

Group type: EXPERIMENTAL
Intervention: Chemoprevention of keratinocyte carcinomas (specific intervention details not provided)
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Higher actinic keratoses (AK) count
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Past 5-fluorouracil (5-FU) use
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Higher comorbidities
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Number of previous KCs
Number of subjects: 931
Study: 17118512

Group type: EXPERIMENTAL
Intervention: CPR with automated external defibrillators (AEDs)
Number of subjects: 19320

Group type: COMPARATOR
Intervention: CPR-only
Number of subjects: 19320

Group type: EXPERIMENTAL
Intervention: Previous emergency training
Number of subjects: 19320

Group type: EXPERIMENTAL
Intervention: Supervisory/management or security personnel
Number of subjects: 19320

Group type: EXPERIMENTAL
Intervention: Previous CPR training
Number of subjects: 19320

Group type: EXPERIMENTAL
Intervention: Previous experience in emergency care
Number of subjects: 19320

Group type: EXPERIMENTAL
Intervention: Formal education beyond high school
Number of subjects: 19320
Study: 15688687

Group type: EXPERIMENTAL
Intervention: Supplementing the kidney and invigorating blood flow
Number of subjects: 248

Group type: COMPARATOR
Intervention: Western drugs
Number of subjects: 248
Study: 12494409

Group type: EXPERIMENTAL
Intervention: Amicus
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Spectra
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CS3000+
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MCS Plus
Number of subjects: 20
Study: 10619639

Group type: EXPERIMENTAL
Intervention: Normal face
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scattered face
Number of subjects: 0
Study: 7776159

Group type: EXPERIMENTAL
Intervention: Device 1 (D-1)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Device 2 (D-2)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Day to day variation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Menstrual cycle effect
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Smoking habit effect
Number of subjects: 9
Study: 1970107

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) measurement
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Adrenocorticotropin (ACTH) measurement
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Prolactin measurement
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Growth hormone measurement
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: LH and FSH measurement
Number of subjects: 9
Study: 7428415

Group type: EXPERIMENTAL
Intervention: Clotrimazole (200 mg vaginal tablets)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Econazole (150 mg vaginal ovules)
Number of subjects: 111
Study: 31317694

Group type: EXPERIMENTAL
Intervention: Frankincense consumption (500 mg pills, two times a day for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 27808536

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 113
Study: 26745694

Group type: EXPERIMENTAL
Intervention: Iniparib 8 mg/kg intravenously on days 1 and 4 weekly
Number of subjects: 12
Study: 25065093

Group type: EXPERIMENTAL
Intervention: 400 ml 10% CHO drink preoperative night and 2 hours before anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no CHO drink)
Number of subjects: 100
Study: 22085803

Group type: EXPERIMENTAL
Intervention: Web-based version of the Community Reinforcement Approach, in addition to prize-based contingency management
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 500
Study: 20384013

Group type: EXPERIMENTAL
Intervention: International assistant referees (ARs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: National assistant referees (ARs)
Number of subjects: 0
Study: 17973781

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 15459842

Group type: EXPERIMENTAL
Intervention: PGF(2alpha) analogues (n = 78)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Carbonic anhydrase inhibitors (n = 26)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Combination of PGF(2alpha) analogues and carbonic anhydrase inhibitors (n = 41)
Number of subjects: 403

Group type: COMPARATOR
Intervention: None of these drugs (n = 258)
Number of subjects: 403
Study: 11665499

Group type: EXPERIMENTAL
Intervention: Basic educational programme
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Asthma school programme
Number of subjects: 40
Study: 10346660

Group type: EXPERIMENTAL
Intervention: Single bout of strength training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Other control condition (Control)
Number of subjects: 24
Study: 7978476

Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 2686424

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin (200 mg every 12 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous ceftazidime (1 g every eight hours)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 60
Study: 4627093

Group type: EXPERIMENTAL
Intervention: disodium cromoglycate with isoprenaline
Number of subjects: 53

Group type: COMPARATOR
Intervention: lactose with isoprenaline (placebo)
Number of subjects: 53
Study: 30594886

Group type: EXPERIMENTAL
Intervention: Peer-led asthma self-management program (n=35, ages 16-20 years)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Peer-led asthma self-management program
Number of subjects: 259

Group type: COMPARATOR
Intervention: Healthcare professionals (control group)
Number of subjects: 259
Study: 28646976

Group type: EXPERIMENTAL
Intervention: REDI‐P (16‐session home‐visiting intervention)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: REDI‐P
Number of subjects: 200
Study: 25147345

Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 18
Study: 22182228

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (dl‐alpha‐tocopherol acetate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (non-supplemented buffaloes)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (VeC and CC)
Number of subjects: 20
Study: 22332049

Group type: EXPERIMENTAL
Intervention: Activity and nutrition environmental intervention
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control
Number of subjects: 13
Study: 19327425

Group type: EXPERIMENTAL
Intervention: Exercise training (E)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment (C)
Number of subjects: 50
Study: 16776698

Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion
Number of subjects: 20
Study: 15562199

Group type: EXPERIMENTAL
Intervention: HIM2 (0.125 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HIM2 (0.5 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HIM2 (0.75 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: HIM2 and lispro insulin
Number of subjects: 6
Study: 11750294

Group type: EXPERIMENTAL
Intervention: Stress management programme
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (25 subjects who did not participate in stress management)
Number of subjects: 27
Study: 9430857

Group type: EXPERIMENTAL
Intervention: Loop diuretics (torasemide, frusemide)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Non-oliguric patients
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Oliguric patients
Number of subjects: 92
Study: 7900662

Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg, maximum 150 mg)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (7 mg/kg)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Flecainide vs Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 98
Study: 2693180

Group type: EXPERIMENTAL
Intervention: Nissen procedure
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Toupet procedure
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lortat-Jacob procedure
Number of subjects: 52
Study: 352468

Group type: EXPERIMENTAL
Intervention: Amitriptyline (150 mg daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31221205

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity counselling intervention
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo control condition (general instructions about health-enhancing physical activity)
Number of subjects: 334
Study: 28870052

Group type: EXPERIMENTAL
Intervention: ERAS perioperative management
Number of subjects: 82

Group type: COMPARATOR
Intervention: Traditional perioperative management (Control)
Number of subjects: 82
Study: 26453638

Group type: EXPERIMENTAL
Intervention: Reusable Goldmann applanation prism
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Disposable Tonosafe prism
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Interobserver variability across all observer groups
Number of subjects: 300
Study: 23374268

Group type: EXPERIMENTAL
Intervention: Intralymphatic allergen-specific immunotherapy (ILIT) with 3 inguinal injections of ALK Alutard (1000 SQ-U birch pollen or grass pollen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (ALK diluent)
Number of subjects: 0
Study: 24198648

Group type: EXPERIMENTAL
Intervention: Oxybutynin chloride topical gel (OTG)
Number of subjects: 727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study: 19815293

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin on alternate days
Number of subjects: 39876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39876
Study: 16904224

Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Ligation
Number of subjects: 179
Study: 14667511

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 0
Study: 11513383

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 6
Study: 9081358

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 1.8 mg/kg
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 2.4 mg/kg
Number of subjects: 474

Group type: COMPARATOR
Intervention: Granisetron 3 mg
Number of subjects: 474
Study: 1862730

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 6851036

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 2800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2800
Study: 29905976

Group type: EXPERIMENTAL
Intervention: Rolapitant (IV) 18 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rolapitant (IV) 36 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rolapitant (IV) 54 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rolapitant (IV)
Number of subjects: 0
Study: 28382669

Group type: EXPERIMENTAL
Intervention: Peaceful Playgrounds™ (P2) intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 4
Study: 25660991

Group type: EXPERIMENTAL
Intervention: Continuing DMARDs (arm 1)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Tapering DMARDs by 50% (arm 2)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Stopping DMARDs after 6 months tapering (arm 3)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall (all arms)
Number of subjects: 101
Study: 24518124

Group type: EXPERIMENTAL
Intervention: Irsogladine (4 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 41
Study: 22018763

Group type: EXPERIMENTAL
Intervention: Prosaccade task
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Antisaccade task
Number of subjects: 11
Study: 19571804

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) monotherapy
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Atenolol monotherapy
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: HCTZ + atenolol combination therapy
Number of subjects: 368

Group type: COMPARATOR
Intervention: Atenolol + HCTZ combination therapy
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Overall BP control
Number of subjects: 368
Study: 17882387

Group type: EXPERIMENTAL
Intervention: Tiger tube (Cook)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bengmark tube (Pfrimmer Nutricia)
Number of subjects: 28
Study: 15167958

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 6367

Group type: EXPERIMENTAL
Intervention: Ex-smokers
Number of subjects: 6367

Group type: EXPERIMENTAL
Intervention: Nonsmokers
Number of subjects: 6367
Study: 12032419

Group type: EXPERIMENTAL
Intervention: Self-selected intensity resistance exercise
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prescribed intensity resistance exercise (75% of 1RM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Quiet rest control
Number of subjects: 19
Study: 9617052

Group type: EXPERIMENTAL
Intervention: Polidocanol 1%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ethanolamine oleate 5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate
Number of subjects: 60